Publication | Open Access
RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer
152
Citations
59
References
2020
Year
RRM2 exerts an anti-ferroptotic role in liver cancer cells by sustaining GSH synthesis. Serum RRM2 will be useful as a biomarker to evaluate the degree to which ferroptosis is suppressed and improve diagnostic efficiency for liver cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1